1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Clinical Trials
Ask MarketMind AI
426.35 -10.25 (-2.35%)
5.5M
NSE+BSE Volume

NSE 07 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

Rising Profit
Biocon’s Q1 profit surges 4.5x YoY on strong biopharma growth and lower interest costs See details

Biocon - BIOCON - stock price prediction, stock forecast, target price, analyst ratings from 19 analysts

Biocon has a share price target of Rs 423, revenue growth forecast of 17.8%, and profit growth estimate of 238.9% for FY27, based on top 19 analyst calls.